Press Release

Statement on tapentadol


The Department of Health and Children wishes to clarify that substances that have legitimate uses as medicines will also be included in the declaration order to be made under the Misuse of Drugs Act. One such product, tapentadol is currently undergoing a procedure for authorisation as a prescription medicinal product in Ireland for the treatment of pain. It will not be banned by the new Misuse of Drugs Regulations.